| [1] |
GASMI B, KLEINER DE. Liver histology: Diagnostic and prognostic features[J]. Clin Liver Dis, 2020, 24(1): 61-74. DOI: 10.1016/j.cld.2019.09.004. |
| [2] |
SHENNAR HK, AL-ASMAR D, KADDOURA A, et al. Diagnosis and clinical features of organic acidemias: A hospital-based study in a single center in Damascus, Syria[J]. Qatar Med J, 2015, 2015(1): 9. DOI: 10.5339/qmj.2015.9. |
| [3] |
VOCKLEY J, ANDERSSON HC, ANTSHEL KM, et al. Phenylalanine hydroxylase deficiency: diagnosis and management guideline[J]. Genet Med, 2014, 16(2): 188-200. DOI: 10.1038/gim.2013.157. |
| [4] |
BOVE KE. 7-histologic patterns of metabolic liver diseases[M]//SAXENA R. Practical hepatic pathology: a diagnostic approach (Second Edition). Philadelphia; Elsevier. 2018: 101-124.
|
| [5] |
KIMURA A, KAGAWA T, TAKEI H, et al. Rotor syndrome: Glucuronidated bile acidemia from defective reuptake by hepatocytes[J]. Hepatol Commun, 2021, 5(4): 629-633. DOI: 10.1002/hep4.1660. |
| [6] |
HADZIYANNIS S, GERBER MA, VISSOULIS C, et al. Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers[J]. Arch Pathol, 1973, 96(5): 327-330.
|
| [7] |
DESDENTADO L, ESPERT R, SANZ P, et al. Lafora disease: a review of the literature[J]. Rev Neurol, 2019, 68(2): 66-74.
|
| [8] |
O'SHEA AM, WILSON GJ, LING SC, et al. Lafora-like ground-glass inclusions in hepatocytes of pediatric patients: a report of two cases[J]. Pediatr Dev Pathol, 2007, 10(5): 351-357. DOI: 10.2350/06-12-01948.1. |
| [9] |
SUMMAR ML, MEW NA. Inborn errors of metabolism with hyperammonemia: Urea cycle defects and related disorders[J]. Pediatr Clin North Am, 2018, 65(2): 231-246. DOI: 10.1016/j.pcl.2017.11.004. |
| [10] |
MATSUMOTO S, HÄBERLE J, KIDO J, et al. Urea cycle disorders-update[J]. J Hum Genet, 2019, 64(9): 833-847. DOI: 10.1038/s10038-019-0614-4. |
| [11] |
BIGOT A, TCHAN MC, THOREAU B, et al Liver involvement in urea cycle disorders: a review of the literature[J]. J Inherit Metab Dis, 2017, 40(6): 757-769. DOI: 10.1007/s10545-017-0088-5. |
| [12] |
HICKS J, WARTCHOW E, MIERAU G. Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment[J]. Ultrastruct Pathol, 2011, 35(5): 183-196. DOI: 10.3109/01913123.2011.601404. |
| [13] |
CHAPMAN J, ARNOLD JK. Reye syndrome[M]. StatPearls. Treasure Island (FL); StatPearls Publishing, Copyright© 2022, StatPearls Publishing LLC. 2022.
|
| [14] |
CORPECHOT C, BARBU V, CHAZOUILLÈRES O, et al. Genetic contribution of ABCC2 to Dubin-Johnson syndrome and inherited cholestatic disorders[J]. Liver Int, 2020, 40(1): 163-174. DOI: 10.1111/liv.14260. |
| [15] |
MORAIS M, COUVERT P, JÉRU I, et al. Rotor syndrome presenting as Dubin-Johnson syndrome[J]. Case Rep Gastroenterol, 2022, 16(2): 452-455. DOI: 10.1159/000525517. |
| [16] |
MARUO Y, NAKAHARA S, YANAGI T, et al. Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type Ⅱ and Gilbert syndrome[J]. J Gastroenterol Hepatol, 2016, 31(2): 403-408. DOI: 10.1111/jgh.13071. |
| [17] |
BHANDARI J, THADA PK, YADAV D. Crigler Najjar syndrome[M]. StatPearls. Treasure Island (FL); StatPearls Publishing, Copyright© 2022, StatPearls Publishing LLC. 2022.
|
| [18] |
Vanishing bile duct syndrome[M]. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD); National Institute of Diabetes and Digestive and Kidney Diseases. 2012.
|
| [19] |
TYAGI I, PURI AS, SAKHUJA P, et al. Co-occurrence of cytomegalovirus-induced vanishing bile duct syndrome with papillary stenosis in HIV infection[J]. Hepatol Res, 2013, 43(3): 311-314. DOI: 10.1111/j.1872-034X.2012.01058.x. |
| [20] |
SHIVARAM PS, GIRISH KP. Alagille syndrome and the liver: current insights[J]. Euroasian J Hepatogastroenterol, 2018, 8(2): 140-147. DOI: 10.5005/jp-journals-10018-1280. |
| [21] |
ROMI L, SAXEN A. Practical hepatic pathology: A diagnostic approach[M]. Elsevier, 2011.
|
| [22] |
ANGELICO R, SENSI B, MANZIA TM, et al. Chronic rejection after liver transplantation: Opening the Pandora's box[J]. World J Gastroenterol, 2021, 27(45): 7771-7783. DOI: 10.3748/wjg.v27.i45.7771. |
| [23] |
KMEID M, LIU X, BALLENTINE S, et al. Idiopathic non-cirrhotic portal hypertension and porto-sinusoidal vascular disease: Review of current data[J]. Gastroenterology Res, 2021, 14(2): 49-65. DOI: 10.14740/gr1376. |
| [24] |
XANTHOPOULOS A, STARLING RC, KITAI T, et al. Heart failure and liver disease: Cardiohepatic interactions[J]. JACC Heart Fail, 2019, 7(2): 87-97. DOI: 10.1016/j.jchf.2018.10.007. |
| [25] |
SHUKLA A, SHRESHTHA A, MUKUND A, et al. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)[J]. Hepatol Int, 2021, 15(3): 531-567. DOI: 10.1007/s12072-021-10189-4. |
| [26] |
LUO WP, MA H, ZHAO XY. Pathological features of hepatic vascular diseases and key points in differential diagnosis[J]. J Clin Hepatol, 2018, 34(11): 2289-2294. DOI: 10.3969/j.issn.1001-5256.2018.11.005. |
DownLoad:
